Tech Company Financing Transactions
Ascletis Funding Round
Ascletis, based in Hangzhou, received $100 million in investment from C-Bridge Capital, Focus Ventures and Goldman Sachs.
Transaction Overview
Company Name
Announced On
1/5/2017
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series B
Investors
Proceeds Purpose
Ascletis plans to use the proceeds from this financing to expand its product portfolio and sales force.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1785 Jianghai Rd. Gemini Internatinal Bldg. No.4 Binjiang Di 1801
Hangzhou, 310000
China
Hangzhou, 310000
China
Phone
Website
Email Address
Overview
Ascletis focuses on building a global specialty therapeutics business dedicated to discovering and developing important new treatments for cancer and infectious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jinzi Wu
Chief Financial Officer
Lindi Tan
VP - Operations
Judy Wu
VP - Regulatory Affairs
Vivian Chen
VP - Sales
Helen Yan
Browse more venture capital transactions:
Prev: 1/5/2017: Rockets of Awesome venture capital transaction
Next: 1/5/2017: Sonendo venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs